Part of the Ca2+ signaling cascade, calmodulin kinase type II gamma (CaMKIIγ), plays an important role in tumor progression of prostate cancer by activation of AKT in a PI3K-independent manner [30], or in the development of colitis-associated cancer through activation of STAT3 [31]. This evidence concerns the gene STAT3 and prostate carcinoma.